Chemomab Therapeutics Ltd. (CMMB)
NASDAQ: CMMB · Real-Time Price · USD
1.640
-0.050 (-2.96%)
Dec 30, 2025, 3:35 PM EST - Market open
Chemomab Therapeutics Market Cap
Chemomab Therapeutics has a market cap or net worth of $10.09 million as of December 30, 2025. Its market cap has decreased by -69.23% in one year.
Market Cap
10.09M
Enterprise Value
407.08K
1-Year Change
-69.23%
Ranking
Category
Stock Price
$1.64
Market Cap Chart
Since March 17, 2021, Chemomab Therapeutics's market cap has decreased from $631.18M to $10.09M, a decrease of -98.40%. That is a compound annual growth rate of -57.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 29, 2025 | 10.40M | -69.52% |
| Dec 31, 2024 | 34.13M | 466.14% |
| Dec 29, 2023 | 6.03M | -83.65% |
| Dec 30, 2022 | 36.88M | -53.12% |
| Dec 31, 2021 | 78.67M | -87.54% |
| Mar 17, 2021 | 631.18M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 964.97B |
| Johnson & Johnson | 498.05B |
| AbbVie | 405.53B |
| UnitedHealth Group | 303.27B |
| AstraZeneca | 287.56B |
| Novartis AG | 266.91B |
| Merck & Co. | 263.14B |
| Novo Nordisk | 229.27B |